- Home
- ETWO vs BBNX Comparison
ETWO vs BBNX Comparison
Compare ETWO & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETWO
- BBNX
- Stock Information
- Founded
- ETWO 2000
- BBNX 2015
- Country
- ETWO United States
- BBNX United States
- Employees
- ETWO N/A
- BBNX N/A
- Industry
- ETWO EDP Services
- BBNX Medical/Dental Instruments
- Sector
- ETWO Technology
- BBNX Health Care
- Exchange
- ETWO Nasdaq
- BBNX Nasdaq
- Market Cap
- ETWO 663.4M
- BBNX 578.8M
- IPO Year
- ETWO N/A
- BBNX 2025
- Fundamental
- Price
- ETWO $3.28
- BBNX $13.79
- Analyst Decision
- ETWO Sell
- BBNX Strong Buy
- Analyst Count
- ETWO 4
- BBNX 10
- Target Price
- ETWO $2.78
- BBNX $25.20
- AVG Volume (30 Days)
- ETWO 3.2M
- BBNX 470.7K
- Earning Date
- ETWO 07-10-2025
- BBNX 07-29-2025
- Dividend Yield
- ETWO N/A
- BBNX N/A
- EPS Growth
- ETWO N/A
- BBNX N/A
- EPS
- ETWO N/A
- BBNX N/A
- Revenue
- ETWO $609,135,000.00
- BBNX $69,830,000.00
- Revenue This Year
- ETWO $1.84
- BBNX $32.71
- Revenue Next Year
- ETWO $2.32
- BBNX $37.37
- P/E Ratio
- ETWO N/A
- BBNX N/A
- Revenue Growth
- ETWO N/A
- BBNX 38911.17
- 52 Week Low
- ETWO $1.75
- BBNX $8.89
- 52 Week High
- ETWO $4.82
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- ETWO 67.25
- BBNX N/A
- Support Level
- ETWO $3.21
- BBNX N/A
- Resistance Level
- ETWO $3.24
- BBNX N/A
- Average True Range (ATR)
- ETWO 0.01
- BBNX 0.00
- MACD
- ETWO -0.02
- BBNX 0.00
- Stochastic Oscillator
- ETWO 87.50
- BBNX 0.00
About ETWO E2open Parent Holdings Inc.Class A
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.